Reid Laurence bought MGX
September 9, 2026 · Form 4 insider transaction
Reid Laurence bought 19,883 shares of Metagenomi Therapeutics, Inc. at $1.17 per share, a transaction worth $23.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
19,883
Price
$1.17
Total value
$23.3K
InsiderReid Laurence
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 9, 2026
Filing dateSeptember 11, 2026
Shares owned after19,883
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.165 to $1.175. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.